Changeflow GovPing Pharma & Drug Safety KWS SAAT Immature Inflorescence Meristem Gene E...
Routine Notice Added Final

KWS SAAT Immature Inflorescence Meristem Gene Editing

Favicon for changeflow.com USPTO Patent Applications - Biotech (C12N)
Published
Detected
Email

Summary

KWS SAAT SE & Co. KGaA has published a patent application (US20260098273A1) for a method of plant genome modification targeting immature inflorescence meristem (IIM) cells. The method uses genome editing systems with optional regeneration boosters, delivered via particle bombardment, to modify genomic target sites in plant cells and regenerate modified plant tissues, organs, or seeds.

What changed

KWS SAAT SE & Co. KGaA published a patent application covering methods for modifying plant genomes using immature inflorescence meristem (IIM) cells as the target cell type. The invention provides genome editing or editing systems with optional regeneration boosters, delivered via particle bombardment, along with tools, constructs, and strategies for modifying genomic target sites and regenerating modified plant cells into tissues, organs, plants, or seeds.

Affected parties including agricultural biotechnology companies, plant breeders, and crop researchers should monitor this patent filing for potential licensing implications or freedom-to-operate considerations. The application covers CPC classifications related to plant gene sequences (C12N 15/8213) and plant cell cultures (C12N 5/0025).

What to do next

  1. Monitor for updates

Archived snapshot

Apr 13, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

IMMATURE INFLORESCENCE MERISTEM EDITING

Application US20260098273A1 Kind: A1 Apr 09, 2026

Assignee

KWS SAAT SE & Co. KGaA

Inventors

Ling MENG

Abstract

The present invention relates to a method for plant genome modification of at least one plant cell being in the developmental stage of a plant immature inflorescence meristem (IIM) cell, wherein the modification of the specific cell type is achieved by providing a genome modification or editing system, optionally together with at least one regeneration booster, preferably wherein the effector molecules are introduced by means of particle bombardment. To this end, new artificial and precisely controllable booster genes and proteins are provided. Further, the modified plant cells are regenerated in a direct or an indirect way. Finally, methods, tools, constructs and strategies are provided to effectively modify at least one genomic target site in a plant cell, to obtain said modified cell and to regenerate a, plant tissue, organ, plant or seed from such modified cell.

CPC Classifications

C12N 15/8213 C12N 5/0025 C12N 15/821 C12N 2310/20

Filing Date

2025-10-14

Application No.

19358081

View original document →

Get daily alerts for USPTO Patent Applications - Biotech (C12N)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 9th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260098273A1

Who this affects

Applies to
Agricultural firms
Industry sector
1111 Crop Production
Activity scope
Plant genome editing Plant breeding Genetic modification
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Genetic Engineering Agriculture

Get alerts for this source

We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!